The company's fourth quarter revenues fell 34 percent as COVID testing dried up, but full-year 2022 revenues grew 52 percent year over year.
In Brief This Week: Standard BioTools, Ocean Genomics, Oxford Nanopore, Ginkgo Bioworks, More
News items for the week of Feb. 13, 2023.
In Brief This Week: Meridian Bioscience, SQI Diagnostics, Applied DNA, Abbott, Danaher, More
News items for the week of Feb. 6, 2023.
Ginkgo Bioworks Partners With Ukraine on Wastewater Testing; CDC on Flu Monitoring
The announcements come a week after Ginkgo announced that it would meet its full-year 2022 revenue guidance on the strength of biosecurity revenues.
Ginkgo Bioworks Expects to Meet 2022 Revenue Guidance Despite Foundry Services Shortfall
The synthetic biology firm still expects full-year 2022 revenues in the range of $460 million to $480 million and 55 to 60 new cell programs.
Oct 4, 2022
Ginkgo Bioworks Acquires Circularis, Altar
May 16, 2022
Ginkgo Bioworks Q1 Revenues More Than Triple
Mar 28, 2022